Inari Medical Other Share Holders Equity 2019-2024 | NARI
Inari Medical other share holders equity from 2019 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Inari Medical Annual Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $0 |
| Inari Medical Quarterly Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2018-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.972B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.277B | 25.29 |
| Intuitive Surgical (ISRG) | United States | $191.158B | 99.94 |
| Alcon (ALC) | Switzerland | $43.154B | 28.88 |
| Edwards Lifesciences (EW) | United States | $39.233B | 24.91 |
| IQVIA Holdings (IQV) | United States | $38.389B | 21.15 |
| IDEXX Laboratories (IDXX) | United States | $35.196B | 41.45 |
| DexCom (DXCM) | United States | $28.330B | 42.67 |
| Waters (WAT) | United States | $22.897B | 33.86 |
| STERIS (STE) | Ireland | $21.940B | 25.26 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.323B | 0.00 |
| Hologic (HOLX) | United States | $18.391B | 19.41 |
| Sysmex ADR (SSMXY) | Japan | $12.594B | 39.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.359B | 12.69 |
| Globus Medical (GMED) | United States | $11.177B | 28.46 |
| Penumbra (PEN) | United States | $9.059B | 88.74 |
| Teleflex (TFX) | United States | $9.009B | 14.37 |
| Masimo (MASI) | United States | $8.656B | 41.89 |
| Glaukos (GKOS) | United States | $7.898B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.814B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.614B | 26.15 |
| TransMedics (TMDX) | United States | $3.112B | 98.65 |
| Veracyte (VCYT) | United States | $3.064B | 91.93 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.80 |
| Nihon Kohden (NHNKY) | Japan | $2.563B | 19.47 |
| Elekta AB (EKTAY) | Sweden | $2.202B | 17.94 |
| Tandem Diabetes Care (TNDM) | United States | $1.949B | 0.00 |
| RxSight (RXST) | United States | $1.800B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.799B | 9.40 |
| Alphatec Holdings (ATEC) | United States | $1.294B | 0.00 |
| Artivion (AORT) | United States | $1.141B | 75.58 |
| OPKO Health (OPK) | United States | $1.092B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.070B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.896B | 15.23 |
| Paragon 28 (FNA) | United States | $0.862B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.712B | 0.00 |
| IRadimed (IRMD) | United States | $0.703B | 37.98 |
| OrthoPediatrics (KIDS) | United States | $0.587B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.585B | 13.80 |
| AxoGen (AXGN) | United States | $0.552B | 0.00 |
| SiBone (SIBN) | United States | $0.551B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.493B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.389B | 21.07 |
| Semler Scientific (SMLR) | United States | $0.345B | 23.19 |
| CVRx (CVRX) | United States | $0.345B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.302B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.301B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.284B | 0.00 |
| NeuroPace (NPCE) | United States | $0.267B | 0.00 |
| Inogen (INGN) | United States | $0.246B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Nevro (NVRO) | United States | $0.167B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.113B | 16.78 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.086B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.084B | 0.00 |
| 908 Devices (MASS) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.051B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| Neuronetics (STIM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |